#smallcapcentral: tryp therapeutics (asx: typ) completes phase 2a fibromyalgia trial
Published 2 months ago • 45 plays • Length 0:37Download video MP4
Download video MP3
Similar videos
-
0:51
🛎️ #smallcapcentral: positive phase 2a #fibromyalgia results for #tryptaminetherapeutics (#asx:#typ)
-
0:57
tryp therapeutics successfully completes maiden dosing of iv-infused psilocin in a world-first #typ
-
2:22
small cap central: clinical progress for biotechs tryp & trivarx; production online for axp energy
-
0:47
#tryptaminetherapeutics (asx:typ) appointed #lucidhealthconsulting for trp-8803 strategy
-
4:38
tryptamine therapeutics completes phase 1b of iv-infused psilocin trial
-
5:06
tryptamine therapeutics delivers fibromyalgia trial results breakthrough
-
9:27
biotech tryp therapeutics hits the asx with a bang
-
13:41
tryptamine therapeutics launches on asx with innovative psilocin formulation
-
15:23
fluence corporation limited - asx small & mid-cap conference
-
6:11
argenica therapeutics with proactive at the asx small and mid-cap conference
-
12:58
tryp therapeutics ceo greg mckee: “about ready” to initiate two phase 2a studies
-
7:10
tryp therapeutics, greg mckee, chairman & ceo
-
6:39
tryp therapeutics new ceo looking to take big steps this year with a number of partnerships
-
56:29
neurotech international (asx:nti) - rett syndrome phase i/ii results
-
26:27
asx small & mid cap conference starpharma holdings limited
-
16:15
alterity therapeutics (asx:ath) - webinar presentation
-
20:49
asx small & mid cap conference volpara health technologies limited